Study ID: TVP1012-PK-10002
Study Title
- A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Rasagiline
Teva Identifier
- TVP1012-PK-10002
ClinicalTrials.gov Identifier
- NCT01879748
Study Status
- Completed
Trial Condition(s)
- Parkinson's Disease
Interventions
- Drug: Rasagiline | Drug: Placebo
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 20 Years to 50 Years
Trial Duration
- 06/01/2013 - 11/01/2013
Phase
- Phase 1
Study Type
Interventional
